Intra-operative Detection of Positive Margins and Lymph Nodes in Breast Surgery
NCT06977698 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2026-07-30
Summary
In this project, the investigators will develop novel optical coherence tomography (OCT)-Raman spectroscopy and autofluorescence (AF)-Raman spectroscopy systems based on a selective sampling approach optimised for high-resolution analysis of whole lumpectomy specimens and sentinel lymph node (SLN) biopsies, respectively. The aim of using optical coherence tomography is not to detect cancer directly, but rather to identify adipose tissue so that large adipose regions can be excluded from subsequent Raman spectroscopy measurements.
Although OCT has limited ability to distinguish tumour tissue from the surrounding normal stroma, adipose tissue exhibits a distinctive appearance in optical coherence tomography images because of its low backscattering properties, resulting from adipocytes that are filled with lipids and contain small, flattened nuclei. In contrast, benign dense tissue (stroma, ducts, and lobules) and malignant tissue produce much stronger backscattering signals. These characteristic patterns enable adipose tissue to be distinguished from other breast tissues using classification models based on optical coherence tomography reflectivity profiles, achieving 94% sensitivity and 93% specificity. Excluding adipose tissue from further analysis reduces the number of Raman spectroscopy measurements required, allowing the remaining, smaller tissue regions to be examined to discriminate between benign and malignant tissue. This flexible and adaptable scanning strategy is expected to improve both diagnostic accuracy and scanning speed, enabling complete assessment of surgical margins within clinically practical timescales.
In addition, the investigators will develop a novel (AF)-Raman spectroscopy system based on a selective sampling approach optimised for high-resolution analysis of sentinel lymph node specimens. The purpose of incorporating autofluorescence imaging is to identify the optimal sampling locations for subsequent Raman spectroscopy measurements, thereby improving the efficiency of tissue interrogation while maintaining diagnostic accuracy.
Conditions
- Breast Cancer Invasive
Interventions
- DIAGNOSTIC_TEST
-
OCT-Raman
a machine to detect positive margins in lumpectomy specimens
- DIAGNOSTIC_TEST
-
AF-Raman
a machine for detection sentinel lymph nodes in Breast conserving surgery.
Sponsors & Collaborators
-
University of Nottingham
lead OTHER
Principal Investigators
-
Ioan Notingher · University of Nottingham
-
Andrew Green · University of Nottingham
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-10-01
- Primary Completion
- 2027-04-01
- Completion
- 2027-04-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Label-free Raman Spectroscopy for Discrimination Between Breast Cancer Tumor and Adjacent Tissues After Neoadjuvant Treatment
NCT06394050 ·Status: NOT_YET_RECRUITING
-
Contrast-Free Magnetic Resonance Imaging for Breast Disease
NCT05006196 ·Status: ACTIVE_NOT_RECRUITING
-
Real Time Optical Coherence Tomography (OCT) of Human Tissue
NCT01506700 ·Status: TERMINATED
-
A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins
NCT01372631 ·Status: COMPLETED ·Phase: NA
-
Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors
NCT00625417 ·Status: COMPLETED ·Phase: NA
-
Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast Cancers
NCT02701348 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Breast Cancer Surgical Margins Using Optical Spectroscopy
NCT00214292 ·Status: COMPLETED ·Phase: NA
-
Using Diagnostic Tools to Stage Breast Cancer
NCT00367666 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Wide-field Optical Coherence Tomography Imaging of Excised Breast Tissue.
NCT04242277 ·Status: COMPLETED
-
A Prospective Study to Evaluate FDG-PET, Breast MRI, and Breast Ultrasonography in Monitoring Tumour Responses in Patients With Locally Advanced Breast Cancer (LABC) Undergoing Neoadjuvant Chemotherapy
NCT00788489 ·Status: COMPLETED
-
Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy
NCT00734838 ·Status: COMPLETED ·Phase: NA
-
LightPathTM Imaging System for Ex-vivo Assessment of Margin and Lymph Node Status in Breast Cancer Surgical Specimens
NCT02037269 ·Status: COMPLETED
-
Trop2-targeting NIR-II Molecular Probe for Breast Cancer Precise Surgery
NCT06713681 ·Status: COMPLETED
-
Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B)
NCT02313116 ·Status: SUSPENDED
-
Magnetic Resonance Breast Tissue Characterisation to Improve Risk Stratification for Breast Cancer
NCT03684733 ·Status: COMPLETED
-
Prospective Ultrafast MRI Radiomics for Breast Cancer
NCT06104189 ·Status: COMPLETED
-
Is Lipid Mapping an Effective Early Detection Tool for Breast Cancer in High-risk Populations?
NCT03949946 ·Status: UNKNOWN
-
Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Status
NCT06713161 ·Status: RECRUITING
-
Clinical Explorative Optical Breast Investigations
NCT06857669 ·Status: RECRUITING ·Phase: NA
-
Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis
NCT00610467 ·Status: TERMINATED ·Phase: NA
-
Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease
NCT00312637 ·Status: WITHDRAWN ·Phase: NA
-
Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography and MRI
NCT00695968 ·Status: TERMINATED
-
MR Characterisation/Localisation of Breast Cancer
NCT01567137 ·Status: COMPLETED
-
A Study to Correlate Ultrasound Elastography With Histopathology to Monitor the Response of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy
NCT01737970 ·Status: COMPLETED
-
Fast Spectral Imaging Device for Tumor Margin Mapping
NCT01107080 ·Status: COMPLETED